Altiora Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Hold
898
– – 0.17% 53
2026
Q2
$1.08M Buy
898
+3
+0.3% +$3.06K 0.17% 54
2026
Q1
$823K Sell
895
-8
-0.9% -$8.11K 0.14% 59
2025
Q4
$970K Sell
903
-41
-4% -$39.2K 0.17% 53
2025
Q3
$720K Hold
944
– – 0.13% 54
2025
Q2
$736K Hold
944
– – 0.14% 54
2025
Q1
$780K Sell
944
-30
-3% -$25K 0.17% 52
2024
Q4
$752K Buy
974
+336
+53% +$278K 0.16% 54
2024
Q3
$565K Hold
638
– – 0.13% 66
2024
Q2
$578K Buy
638
+41
+7% +$32.8K 0.14% 59
2024
Q1
$464K Sell
597
-16
-3% -$11.4K 0.13% 60
2023
Q4
$357K Buy
613
+159
+35% +$92.8K 0.1% 62
2023
Q3
$244K Buy
+454
New +$234K 0.11% 53

Other funds holding LLY

Altiora Financial Group's LLY Position: Q3 2026 in Review

Altiora Financial Group held its Eli Lilly (LLY) position steady in Q3 2026 at 898 shares worth $1.04M. The position accounts for 0.17% of the portfolio, ranked #53.

Altiora Financial Group first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.08M in Q2 2026. 3,844 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Altiora Financial Group held 898 shares of Eli Lilly worth $1.04M as of Q3 2026.
  • Altiora Financial Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.17% of Altiora Financial Group's portfolio in Q3 2026, its #53 holding.
  • Altiora Financial Group first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • Altiora Financial Group's Eli Lilly position peaked at $1.08M in Q2 2026.
  • 3,844 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Altiora Financial Group's 13F filing for Q3 2026, filed 4 Nov 2026.